Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

By Sector

By Industry

Sep 1, 2026
Sale
Shares
2,085
Price
$4.05
Total Value
$8.44K
Shares Held After
247,733
% of Holdings
0.8%
Sep 1, 2026
Sale
Shares
1,020
Price
$4.05
Total Value
$4.13K
Shares Held After
249,818
% of Holdings
0.4%
Sep 1, 2026
Sale
Shares
2,515
Price
$4.05
Total Value
$10.19K
Shares Held After
250,838
% of Holdings
1.0%

GeneDx Holdings Corp. (WGS)

Feeley Kevin — CHIEF FINANCIAL OFFICER
Sep 1, 2026
Sale
Shares
372
Price
$83.84
Total Value
$31.19K
Shares Held After
40,299
% of Holdings
0.9%

Fiverr International Ltd. (FVRR)

Qian Jinjin — Chief Business Officer
Sep 1, 2026
Sale
Shares
3,961
Price
$9.31
Total Value
$36.88K
Shares Held After
104,921
% of Holdings
3.6%

Atomera Inc (ATOM)

BIBAUD SCOTT A. — Director
Sep 1, 2026
Sale
Shares
5,446
Price
$4.05
Total Value
$22.06K
Shares Held After
682,005
% of Holdings
0.8%

Atomera Inc (ATOM)

BIBAUD SCOTT A. — Director
Sep 1, 2026
Sale
Shares
4,515
Price
$4.05
Total Value
$18.29K
Shares Held After
687,451
% of Holdings
0.7%

Atomera Inc (ATOM)

BIBAUD SCOTT A. — Director
Sep 1, 2026
Sale
Shares
1,988
Price
$4.05
Total Value
$8.05K
Shares Held After
691,966
% of Holdings
0.3%

Atomera Inc (ATOM)

BIBAUD SCOTT A. — Director
Sep 1, 2026
Sale
Shares
1,807
Price
$4.05
Total Value
$7.32K
Shares Held After
693,954
% of Holdings
0.3%
Sep 1, 2026
Sale
Shares
2,005
Price
$74.43
Total Value
$149.23K
Shares Held After
139,224
% of Holdings
1.4%
Sep 1, 2026
Sale
Shares
10,495
Price
$73.52
Total Value
$771.57K
Shares Held After
141,229
% of Holdings
6.9%

Lucid Group, Inc. (LCID)

Winitzer Ori — Director
Sep 1, 2026
Sale
Shares
1,000
Price
$4.80
Total Value
$4.80K
Shares Held After
66,263
% of Holdings
1.5%
Sep 1, 2026
Sale
Shares
31,908
Price
$26.29
Total Value
$838.78K
Shares Held After
223,355
% of Holdings
12.5%
Sep 1, 2026
Sale
Shares
2,593
Price
$26.31
Total Value
$68.21K
Shares Held After
18,151
% of Holdings
12.5%
Sep 1, 2026
Sale
Shares
465
Price
$60.75
Total Value
$28.25K
Shares Held After
48,300
% of Holdings
1.0%

URBAN OUTFITTERS INC (URBN)

Egan Mary — Director
Sep 1, 2026
Sale
Shares
650
Price
$78.48
Total Value
$51.01K
Shares Held After
15,700
% of Holdings
4.0%

Palo Alto Networks Inc (PANW)

Paul Josh D. — Chief Accounting Officer
Sep 1, 2026
Sale
Shares
900
Price
$373.68
Total Value
$336.31K
Shares Held After
72,484
% of Holdings
1.2%
Sep 1, 2026
Sale
Shares
1
Price
$79.95
Total Value
$79.95
Shares Held After
14,012
% of Holdings
0.0%
Sep 1, 2026
Sale
Shares
58
Price
$79.95
Total Value
$4.64K
Shares Held After
337,427
% of Holdings
0.0%
Sep 1, 2026
Sale
Shares
70
Price
$79.95
Total Value
$5.60K
Shares Held After
349,140
% of Holdings
0.0%

CASTLE BIOSCIENCES INC (CSTL)

Oelschlager Kristen M — Chief Operating Officer
Sep 1, 2026
Sale
Shares
200
Price
$34.02
Total Value
$6.80K
Shares Held After
13,356
% of Holdings
1.5%

CASTLE BIOSCIENCES INC (CSTL)

Oelschlager Kristen M — Chief Operating Officer
Sep 1, 2026
Sale
Shares
3,952
Price
$33.36
Total Value
$131.84K
Shares Held After
13,556
% of Holdings
22.6%
Sep 1, 2026
Sale
Shares
481
Price
$92.09
Total Value
$44.29K
Shares Held After
551,270
% of Holdings
0.1%
Sep 1, 2026
Sale
Shares
4,912
Price
$91.03
Total Value
$447.12K
Shares Held After
551,751
% of Holdings
0.9%
Sep 1, 2026
Sale
Shares
4,607
Price
$90.47
Total Value
$416.80K
Shares Held After
556,663
% of Holdings
0.8%
Sep 1, 2026
Sale
Shares
250
Price
$65.55
Total Value
$16.39K
Shares Held After
30,844
% of Holdings
0.8%

VERACYTE, INC. (VCYT)

Bhanji Muna — Director
Sep 1, 2026
Sale
Shares
1,864
Price
$42.97
Total Value
$80.10K
Shares Held After
42,718
% of Holdings
4.2%
Sep 1, 2026
Sale
Shares
100
Price
$30.02
Total Value
$3.00K
Shares Held After
6,808,182
% of Holdings
0.0%
Sep 1, 2026
Sale
Shares
400
Price
$89.38
Total Value
$35.75K
Shares Held After
2,845
% of Holdings
12.3%
Sep 1, 2026
Sale
Shares
6,206
Price
$88.17
Total Value
$547.18K
Shares Held After
3,245
% of Holdings
65.7%
Sep 1, 2026
Sale
Shares
16,548
Price
$87.20
Total Value
$1.44M
Shares Held After
9,451
% of Holdings
63.6%
Sep 1, 2026
Sale
Shares
4,845
Price
$86.40
Total Value
$418.61K
Shares Held After
25,999
% of Holdings
15.7%

Oddity Tech Ltd (ODD)

Drucker Mann Lindsay — Global Chief Financial Officer
Sep 1, 2026
Sale
Shares
7,717
Price
$15.09
Total Value
$116.45K
Shares Held After
116,135
% of Holdings
6.2%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sep 1, 2026
Sale
Shares
2,281
Price
$115.61
Total Value
$263.71K
Shares Held After
9,755
% of Holdings
19.0%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sep 1, 2026
Sale
Shares
10,989
Price
$114.71
Total Value
$1.26M
Shares Held After
12,036
% of Holdings
47.7%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sep 1, 2026
Sale
Shares
11,730
Price
$113.94
Total Value
$1.34M
Shares Held After
23,025
% of Holdings
33.8%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Sep 1, 2026
Sale
Shares
600
Price
$321.91
Total Value
$193.14K
Shares Held After
126,019
% of Holdings
0.5%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Sep 1, 2026
Sale
Shares
1,400
Price
$320.92
Total Value
$449.29K
Shares Held After
126,619
% of Holdings
1.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Sep 1, 2026
Sale
Shares
1,000
Price
$319.76
Total Value
$319.76K
Shares Held After
128,019
% of Holdings
0.8%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Sep 1, 2026
Sale
Shares
200
Price
$89.04
Total Value
$17.81K
Shares Held After
97,994
% of Holdings
0.2%
Sep 1, 2026
Sale
Shares
400
Price
$89.07
Total Value
$35.63K
Shares Held After
552,540
% of Holdings
0.1%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Sep 1, 2026
Sale
Shares
2,016
Price
$88.03
Total Value
$177.47K
Shares Held After
98,194
% of Holdings
2.0%
Sep 1, 2026
Sale
Shares
3,700
Price
$88.06
Total Value
$325.82K
Shares Held After
552,940
% of Holdings
0.7%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Sep 1, 2026
Sale
Shares
4,384
Price
$87.11
Total Value
$381.89K
Shares Held After
100,210
% of Holdings
4.2%
Sep 1, 2026
Sale
Shares
8,400
Price
$87.15
Total Value
$732.06K
Shares Held After
556,640
% of Holdings
1.5%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Sep 1, 2026
Sale
Shares
900
Price
$86.25
Total Value
$77.62K
Shares Held After
104,594
% of Holdings
0.9%
Sep 1, 2026
Sale
Shares
2,500
Price
$86.36
Total Value
$215.90K
Shares Held After
565,040
% of Holdings
0.4%
Sep 1, 2026
Sale
Shares
3,271
Price
$82.54
Total Value
$269.99K
Shares Held After
0
% of Holdings
100.0%
Sep 1, 2026
Sale
Shares
70,329
Price
$81.85
Total Value
$5.76M
Shares Held After
3,271
% of Holdings
95.6%
Sep 1, 2026
Sale
Shares
34,092
Price
$81.20
Total Value
$2.77M
Shares Held After
73,600
% of Holdings
31.7%
Version: v26.7.3